MarcoGenics and Takeda sign a pharma deal for autoimmune diseases
MacroGenics and Takeda Pharmaceutical have entered into an option agreement for pharma deal for the development and commercialization of MGD010. This product candidate incorporates MacroGenics'...
View ArticleTop 50 Pharma (top pharmaceutical companies)
The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Summary Description Examples See Also 'Top 50 Pharma' is the collective name given to the top pharmaceutical...
View ArticleTakeda Pharmaceuticals
Takeda Pharmaceuticals is a top pharmaceutical company based in Osaka, Japan Summary Description Examples See Also Takeda Pharmaceuticals is a top pharmaceutical company based in Osaka, Japan.The...
View ArticleC4X Discovery biopharma partners with Takeda for lead generation
C4X Discovery biopharma partners by signing a research collaboration agreement with Takeda Cambridge Limited. Under the agreement, C4XD's proprietary NMR-based technology will be applied across a...
View ArticleMacroGenics and Takeda sign a pharma licensing deal for $400 million
MacroGenics and Takeda Pharmaceutical announced inking a pharma licensing deal to develop and commercialize four potential product candidates. Earlier in the year the two companies announced announced...
View ArticleTakeda and GE in hepatic fibrosis pact
GE Healthcare and Takeda Pharmaceutical have entered into an alliance agreement for research and development in the field of hepatic fibrosis, a key factor in the diagnosis and treatment of liver...
View ArticleMersana expands fleximer antibody-drug conjugates pact with Takeda
Mersana Therapeutics have expanded their ongoing collaboration with Takeda Pharmaceutical to create novel Fleximer antibody-drug conjugate (ADC) drug candidates to include additional oncology-relevant...
View ArticleTakeda licenses Immunogen’s ADC technology
Takeda has licensed exclusive rights to use ImmunoGen’s ADC technology – including ImmunoGen’s new DNA-acting IGN payload agents – to develop and commercialize targeted anticancer therapeutics to up to...
View ArticleBioXcel and Takeda in repurposing pact for rare diseases
BioXcel has entered into a partnership with Takeda Development Center Americas for the repurposing of assets across the gamut of rare diseases. Through this partnership, Takeda will gain access to and...
View ArticleTakeda and CiRA enter iPS cell research pact
Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical will work together to develop clinical applications of induced pluripotent stem cells in areas such as...
View Article